Atlas Trials

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice

Clinical trial NCT05473286 · WITHDRAWN

Trial details

NCT number
NCT05473286
Sponsor
Novo Nordisk A/S
Status
WITHDRAWN
Study type
OBSERVATIONAL
Diabetes Mellitus, Type 2
Start date
2022-09-30
Primary completion
2024-05-16
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.